TheProfitWatch

SMMT - Summit Therapeutics Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
16.3 0.02 (0.09%) 0.0 (0.0%) -0.02 (-0.12%) 0.04 (0.25%) 0.15 (0.92%) -0.08 (-0.52%) --- 0.15 (0.92%)

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.76
Diluted EPS:
-0.76
Basic P/E:
-21.4671
Diluted P/E:
-21.4671
RSI(14) 1m:
54.35
VWAP:
16.32
RVol:

Events

Period Kind Movement Occurred At

Related News